Keywords: EBV-associated diseases

Micro-immunotherapy & Epstein-Barr Virus Infections

Actives from the Micro-Immunotherapy Medicine 2LMIREG® Reduce the Expression of Cytokines and Immune-Related Markers Including Interleukin-2 and HLA-II While Modulating Oxidative Stress and Mitochondrial Function

Understanding the Mode of Action of a Micro-Immunotherapy Formulation: Pre-Clinical Evidence from the Study of 2LEBV® Active Ingredients

Links of interest

Terms of use
Cookies policy
Data protection policy

Contact Information

If you would like to have more information about micro-immunotherapy and our training activities, do not hesitate to contact us by email or by filling our online contact form.

E-mail: micro-immunotherapy@micro-immunotherapy.com

Scroll To Top